SciELO - Scientific Electronic Library Online

vol.55 issue3The perception of educational assistants and medicine students of the clinical cycle of the FCM-UNA medicine career, on the teaching and learning process of the clinical methodAttitudes, knowledge and behaviors about salt consumption according to the perception of a group of women in Paraguay author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO


Anales de la Facultad de Ciencias Médicas (Asunción)

Print version ISSN 1816-8949


RICO FONTALVO, Jorge et al. Update on diabetic kidney disease. An. Fac. Cienc. Méd. (Asunción) [online]. 2022, vol.55, n.3, pp.86-98. ISSN 1816-8949.


Diabetes mellitus (DM) is a systemic inflammatory disease of high prevalence and incidence worldwide. Among the chronic complications, diabetic kidney disease is one of the most frequent and determines the prognosis.


The objective of this article is to make an updated review of diabetic kidney disease, in light of the changes in the paradigms that have been generated in recent years concerning to the new definitions, the role of inflammation-causing disease, cardiovascular risk management, and the new treatments. Diabetic kidney disease can present in approximately 30-50% of the population with diabetes mellitus type 1 or 2 around the world. In the pathogenesis and progression of this condition, three fundamental axes are distinguished: the hemodynamic, the metabolic, and the inflammatory. It is important to manage cardiovascular risk. The diagnosis must be made by calculating the glomerular filtration rate and the albuminuria/creatinuria ratio in a random urine sample. The objectives of the treatment should be: metabolic control, reduce or slow the progression of kidney disease and improve cardiovascular outcomes.


The treatment of diabetic kidney disease should be holistic, from non-pharmacological interventions, such as lifestyle changes, to new medications such as the use of SGLT-2 inhibitors, GLP-1 receptor agonists, and the use of selective mineralocorticoid receptor antagonists such as finerenone. The future is promising.

Keywords : Diabetes; kidney disease; cardiovascular risk; glomerular filtration rate; guides; holistic..

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )